Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Kima

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Infection and Immunity|May 23, 2003
Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infectionMaría Colmenares, Peter E Kima, Erika Samoff, et al.
The Journal of Biological Chemistry|January 7, 2003
Identification of the human and bovine ATP:Cob(I)alamin adenosyltransferase cDNAs based on complementation of a bacterial mutantNicole A Leal, Sanghee D Park, Peter E Kima, et al.
Plos Neglected Tropical Diseases|July 18, 2014
Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulenceCalvin A Henard, Eric D Carlsen, Christie Hay, et al.
Cellular Microbiology|July 12, 2018
Leishmania parasitophorous vacuole membranes display phosphoinositides that create conditions for continuous Akt activation and a target for miltefosine in Leishmania infectionsNaixin Zhang, Samiksha Prasad, Charles-Eugene Huyghues Despointes, et al.
Plos Neglected Tropical Diseases|October 20, 2010
Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT)Peter E Kima, J Alfredo Bonilla, Eumin Cho, et al.
Plos One|November 7, 2018
Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against LeishmaniaDevki Nandan, Naixin Zhang, Yi Yu, et al.
Life Science Alliance|October 30, 2020
<i>Leishmania</i>-infected macrophages release extracellular vesicles that can promote lesion developmentAnna Gioseffi, Tim Hamerly, Kha Van, et al.
Plos Neglected Tropical Diseases|May 16, 2017
Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infectionsEvan Craig, Charles-Eugene Huyghues-Despointes, Chun Yu, et al.
Parasites & Vectors|April 27, 2023
Increasing temperature denatures canine IgG reducing its ability to inhibit heartworm antigen detectionJeff M Gruntmeir, Jeff R Abbott, Peter E Kima, et al.
Frontiers in Cellular and Infection Microbiology|September 7, 2021
Thermoresponsive Copolymer Nanovectors Improve the Bioavailability of Retrograde Inhibitors in the Treatment of <i>Leishmania</i> InfectionsEvan Craig, Anna Calarco, Raffaele Conte, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Infection and Immunity|May 23, 2003
Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infectionMaría Colmenares, Peter E Kima, Erika Samoff, et al.
The Journal of Biological Chemistry|January 7, 2003
Identification of the human and bovine ATP:Cob(I)alamin adenosyltransferase cDNAs based on complementation of a bacterial mutantNicole A Leal, Sanghee D Park, Peter E Kima, et al.
Plos Neglected Tropical Diseases|July 18, 2014
Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulenceCalvin A Henard, Eric D Carlsen, Christie Hay, et al.
Cellular Microbiology|July 12, 2018
Leishmania parasitophorous vacuole membranes display phosphoinositides that create conditions for continuous Akt activation and a target for miltefosine in Leishmania infectionsNaixin Zhang, Samiksha Prasad, Charles-Eugene Huyghues Despointes, et al.
Plos Neglected Tropical Diseases|October 20, 2010
Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT)Peter E Kima, J Alfredo Bonilla, Eumin Cho, et al.
Plos One|November 7, 2018
Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against LeishmaniaDevki Nandan, Naixin Zhang, Yi Yu, et al.
Life Science Alliance|October 30, 2020
<i>Leishmania</i>-infected macrophages release extracellular vesicles that can promote lesion developmentAnna Gioseffi, Tim Hamerly, Kha Van, et al.
Plos Neglected Tropical Diseases|May 16, 2017
Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infectionsEvan Craig, Charles-Eugene Huyghues-Despointes, Chun Yu, et al.
Parasites & Vectors|April 27, 2023
Increasing temperature denatures canine IgG reducing its ability to inhibit heartworm antigen detectionJeff M Gruntmeir, Jeff R Abbott, Peter E Kima, et al.
Frontiers in Cellular and Infection Microbiology|September 7, 2021
Thermoresponsive Copolymer Nanovectors Improve the Bioavailability of Retrograde Inhibitors in the Treatment of <i>Leishmania</i> InfectionsEvan Craig, Anna Calarco, Raffaele Conte, et al.
Pageof 4